UnknownNot Applicable

Augmented Reality Navigation Versus Traditional CT Guidance for Preoperative Localization of Pulmonary Nodules

China166 participantsStarted 2024-03-14

Plain-language summary

This study aims to conduct a large-sample randomized controlled clinical trial, using traditional CT-guided thoracic puncture localization as a comparison, to explore the accuracy, safety and clinical advantages of Intelligent AR glasses in assisting preoperative localizing of small pulmonary nodules.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 18-80, no gender limit;
✓. Chest CT shows that the nodule involves the outer third of the lung and can be removed by wedge resection;
✓. Chest CT (lung window mode), the maximum diameter of the nodule is ≤2 cm;
✓. Physical condition score ECOG 0-2 points;
✓. If you plan to undergo percutaneous puncture and localization of small pulmonary nodules, the puncture needle path will be determined by the attending physician;
✓. Patients voluntarily participate and sign informed consent.

Exclusion criteria

✕. The lesion is located in front of the scapula, and the needle path is blocked;
✕. The distance between the center of the lesion and the top of the diaphragm is \< 3 cm;
✕. The lesion is adjacent to the hilus or large blood vessels;
✕. Pleural adhesions caused by a history of thoracotomy or pleural infection;
✕. The patient voluntarily withdraws midway.

What they're measuring

Accuracy of puncture localization of pulmonary nodules

Timeframe: Intraoperative

Trial details

NCT IDNCT06335563

SponsorShanghai Pulmonary Hospital, Shanghai, China

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-01

Contact for this trial

Yunlang She, MD

+86 17749739242 sylxan3344@163.com

View on ClinicalTrials.gov More Pulmonary Nodule trials